French pharma group Ipsen sees more asset purchases, U.S. growth

PARIS (Reuters) - French pharma company Ipsen expects to bring more drugs to combat cancer, rare diseases and mobility impairment into its pipeline this year and has around one billion euros ($1.25 billion) for asset purchases, its chief executive said.

from Reuters: Health News http://ift.tt/2Hh2AMX